SCLX
SCLX
NASDAQ · Pharmaceuticals

Scilex Holding Co

$1.98
+0.13 (+7.03%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +1,846.0% upside
Low Target $25.32
Average Target $38.53
High Target $55.24
Current Price $1.98
Current
$1.98
Target
$38.53
$25.32 $38.53 avg $55.24
Scenario Analysis
Bear Case
$25.32
1,178.8%
Low target
Base Case
$38.53
+1,846.0%
Avg target
Bull Case
$55.24
+2,689.9%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$27.00
-92.7% from high
52-Week Low
$2.01
+-1.5% from low
Target vs 52W High
$38.53
+42.7% vs high
Next Earnings Report
Nov 12, 2026
5d
until earnings
Earnings in 5 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -2.5%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +10.0%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.4%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +13.5%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +176.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.3%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +155.6%